Login OPEN ICICI 3-in-1 Account

FORTIS MALAR HOSPITALS SHARE PRICE

Sector Healthcare
BSE 523696
72.45
0.28 (0.39 %)
Buy
B
Sell
S
BSE

Overview

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

Day Low

72.10

Day High

73.50

52 Week Low

51.01

52 Week High

98.70

All Time Low

3.01

All Time High

107.94

Open

73.49

Close

72.17

Volume

12,800

Mkt cap (Cr)

135.79

P/E ratio

345.00

P/B ratio

0.22%

Div yield

0.00%

6M return

24.08%

1Y return

-1.63%

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

72.45 0.39%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Fortis Malar Hospitals Ltd

Stock PE (TTM)

345

Promoter Holding

62.71%

Book Value

16.1094

ROCE

-3.24%

ROE

-9.12%

Fortis Malar Hospital Limited (formerly known as Malar Hospital Limited) was established on April 13, 1989 to set up, manage and operate a multi-specialty hospital. The Company was changed to `Fortis Malar Hospital Limited` on December 21, 2010. The Hospital was acquired by Fortis Group in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multi-speciality healthcare services. With a total bed-strength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal Medicine All the above departments are fully became operational under phase I of the project. The second phase of the project envisages enhacement of the number of beds from 100 to 250 beds at an cost of Rs.2120 lacs. To part the project the company came into rights issues during 1995. The Hospital have started performing Cardio Thoracic surgeries with effect from 13-10-2003. Dr.K M Cherian is leading this cardio Thoracic department. He has won several awards and honors including Padmashree award from the Government. Dr.K M Cherian has conducted around 26,200 cardio thoracic cases including infant heart surgery, heart transplants, paediatric heart transplants and heart and lung transplants. This type of surgery will bring more revenue to the hospital in the comming years. With Dr.K M Cherian at command of cardio thoracic team, the future looks bright. On 7th September 2007 the Company and the Promoters of the Company entered into a Loan, Share Subscription and Share Purchase Agreement (LSSSPA) with International Hospital Ltd, a wholly owned subsidiary of Fortis Healthcare Limited and Oscar Investments Ltd (Acquirer) for the sale of 39,00,000 Equity Shares by the Promoters of the Company and for availing a loan of Rs 14 crores from the Acquirers, convertible into Equity Shares of the Company. Further, the Acquirer Companies acquired 39,00,000 Equity Shares from the Promoters of the Companies on 18th February 2008 which together with their existing holding, constituted 62.17% of the Share Capital of the Company. The Management and Control of Affairs of Company is now with the Acquirers, who consequently shall act as Promoters of the Company. On, 7th July, 2009, Company incorporated a wholly owned subsidiary viz. Malar Stars Medicare Limited. The Board of Directors of Company on August 19, 2016 approved a Composite Scheme of Arrangement and Amalgamation between Company, Fortis Healthcare Limited (FHL), SRL Limited (SRL) and their respective Shareholders and Creditors for (i) the transfer of the undertaking, business and operations of the Company as a going concern, by way of slump sale, from the Company to FHL, (ii) the transfer by way of a demerger of the undertakings, business, activities and operations of FHL, pertaining to diagnostics business of FHL (Demerged Undertaking) to Company, and consequent issue of Equity Shares by Company to Shareholders of FHL; (iii) amalgamation of all the undertakings and entire business of SRL with Company and dissolution of SRL without winding up; the consequent issue of equity shares by Company to the Shareholders of SRL and the cancellation of equity shares of SRL held by Company and various other matters consequential or otherwise integrally connected therewith. Further, National Company Law Tribunal, Chandigarh, vide its order dated June 15, 2018 approved the scheme as withdrawn and accordingly, as on date, the Scheme was terminated by Company, SRL and FHL. Pursuant to execution of Share Subscription Agreement on July 13, 2018 (SSA), Northern TK Venture Pte Ltd (NTK or the Acquirer), a wholly owned subsidiary of IHH Berhard, subscribed to 235,294,117 new equity shares of Fortis Healthcare Limited (FHL) with a face value of Rs 10 each, constituting approximately 31.1% of the total voting equity share capital of FHL on a fully diluted basis for a total consideration of Rs 4,000 crore and FHL issued and allotted the Subscription Shares by way of preferential allotment in accordance with the terms of the SSA. As a consequence of Subscription, the Acquirer together with IHH Healthcare Berhad (PAC 1) and Parkway Pantai Limited (PAC 2), made a mandatory Open Offer, by filing a Public Announcement dated July 13, 2018. The Subscription completed in accordance with the terms of the SSA on November 13, 2018 and NTK became the controlling shareholder of FHL. The entire business operations of the Company have been transferred to MGM Healthcare Pvt Ltd with effect from February 01, 2024, through Business Transfer Agreement.

Fortis Malar Hospitals share price as on 23 Jun 2025 is Rs. 72.45. Over the past 6 months, the Fortis Malar Hospitals share price has increased by 24.08% and in the last one year, it has decreased by 1.63%. The 52-week low for Fortis Malar Hospitals share price was Rs. 51.01 and 52-week high was Rs. 98.7.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

523696

INE842B01015

Jul

Fortis Malar Hospitals Ltd FAQs

You can buy Fortis Malar Hospitals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Fortis Malar Hospitals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 20, 2025 04:01 PM the closing price of Fortis Malar Hospitals Ltd was Rs.72.45.

The latest PE ratio of Fortis Malar Hospitals Ltd as of Jun 20, 2025 04:01 PM is 345.00

The latest PB ratio of Fortis Malar Hospitals Ltd as of Jun 20, 2025 04:01 PM is 0.22

The 52-week high of Fortis Malar Hospitals Ltd share price is Rs. 98.70 while the 52-week low is Rs. 51.01

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 20, 2025 04:01 PM, the market cap of Fortis Malar Hospitals Ltd stood at Rs. 135.79 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.